BREAST CANCER BASE

According to the "Daily Mail" reported on the 11th, the University of Leicester, United Kingdom researchers recently discovered through research, cabbage (cabbage) and MILLER peas (sprouts), the two green vegetables may become the latest anti-breast cancer weapons. Research shows, cabbage and peas contain Miao looks can kill a cancer cell compound I3C, particularly in breast cancer patients undergoing chemotherapy at the same time to eat more vegetables efficacy of the two better.

Prior research has hinted that the two vegetables prevent cancer, but this study was the first for them in the course of breast cancer treatment What is the role of research.

Breast cancer is the most vicious form of the genetic variation from the stem cells. From Walter and Eliza Ho Institute of Medicine scientists used a small model mice found that breast stem cells have not shown estrogen or progesterone receptors. This and other stem cell characteristics, similar to the deterioration of breast cancer among the basal tumor subtype.

There is increasing evidence that breast cancer is not simply a disease. Scientists will now breast cancer as a heterogeneous disease, each composed of seed type. This has led researchers to speculate that breast cancer may originate from stem cells in the breast.

Breast cancer is a common malignancy of women worldwide each year, about 1.2 million women with breast cancer, 50 million people died of breast cancer. In Western Europe, North America and other developed countries, the incidence of breast cancer for women the first.
Virginia Commonwealth University Massey Cancer Center in a new study shows that joint use of two new drugs to kill mice up to 75% of breast tumors and demonstrated a tumor growth inhibition effect. These findings are published in the November 14 issue of Cancer Biology and Therapy magazine's online edition. These new findings also for prostate cancer, lymphoma, myeloma and other blood-cancer treatment, a certain sense.
Biochemical and radiotherapy cancer expert Dr. Paul Dent led the research team in 2002, the research results in live animals for testing.
The new study, the researchers also use two new drugs — UCN-01 and a MEK / 2 inhibitors. Already aware of the two drugs to inhibit protein kinase, part of tumor survival signaling pathways.
Two drugs not only the joint cells and can inhibit tumor growth, but in your own right as well as a new generation of non-cancerous cells are less toxic drugs. Therefore, the researchers will look forward to these exciting discoveries from the laboratory to human transfer of patients either.
When these two drugs separately, the drugs only killed a few cells, and when combined, have the effect was quite startling — the five-day period, the researchers observed that a large number of tumor cell death. These results suggest that the drug combination strategy may be to other breast cancer patients and a great boon.

Sweden and the United Kingdom two research team found that a new cell is the target for the prevention and possible treatment of certain key breast cancer.

Up to 5% of breast cancer in women by BRCA1 and BRCA2 mutations lead. These two genes in normal form is under the function of DNA repair may be the fault of the entire DNA sequence to remove and replace the new. They will lead to variations in breast carcinogenesis. The growth of cancer cells might be unstoppable, but in the growth process, they still need to repair their DNA.